Jennifer D. Tibodeau

Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress

Crescent R. Isham, Jennifer D. Tibodeau, Wendy Jin et al. · Blood · 2006 · 197 citations · Full text

The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase

Jennifer D. Tibodeau, Linda M. Benson, Crescent R. Isham et al. · Antioxidants and Redox Signaling · 2008 · 100 citations · Full text

A Phase 2 Trial of Flavopiridol (Alvocidib) and Cisplatin in Platin-Resistant Ovarian and Primary Peritoneal Carcinoma: MC0261

Keith C. Bible, Prema P. Peethambaram, Ann L. Oberg et al. · Gynecologic Oncology · 2012 · 57 citations

Primary Peritoneal Carcinoma, Platin-resistant Ovarian, Medicine +7

Annatto Constituent Cis-Bixin Has Selective Antimyeloma Effects Mediated by Oxidative Stress and Associated with Inhibition of Thioredoxin and Thioredoxin Reductase

Jennifer D. Tibodeau, Crescent R. Isham, Keith C. Bible · Antioxidants and Redox Signaling · 2010 · 45 citations · Full text

Inflammation, Tumor Biology, Reductive Stress +15

The anticancer effects of chaetocin are independent of programmed cell death and hypoxia, and are associated with inhibition of endothelial cell proliferation

Crescent R. Isham, Jennifer D. Tibodeau, Ayoko R. Bossou et al. · British Journal of Cancer · 2011 · 45 citations · Full text